CYX Calyx Ventures Inc

Calyx Bio-Ventures Inc. ("Calyx" or the "Company") (TSX VENTURE:CYX) announced
today that the analysis on the world's first civil jet flight powered by 100
percent unblended biofuel, conducted by the National Research Council of Canada
("NRC"), is a significant milestone in green aviation and should pave the way
for continued progress to increase the use of biojet fuel. 


NRC flew the first civil jet powered by 100 percent unblended biofuel on October
29, 2012, achieving a milestone for the aviation industry and earning
recognition from Popular Science magazine in their December 2012 issue as one of
"The Big Science Stories of 2012". The biofuel used in the flight was produced
from feedstock by Calyx's operating subsidiary, Agrisoma Biosciences Inc.
("Agrisoma"), and transformed into jet fuel by Applied Research Associates and
Chevron Lummus Global.


NRC announced earlier this week the results of an analysis of the historic
flight, which revealed that the biofuel used in the flight is cleaner than and
as efficient as conventional aviation fuel.


"We are thrilled with the results. The findings confirm our expectations that
biojet fuel, refined from Agrisoma's Resonance(TM) energy feedstock, will play a
significant role in our efforts to further the use of Resonance(TM) based
renewable jet fuel," said Calyx President and CEO Hugh Notman. "It confirms we
can reduce black carbon and aerosol emissions by as much as 50 percent without
sacrificing performance. The result of NRC's study is a big confirmation for our
company, and a bigger nod to the emerging biofuel industry."


The NRC collected in-flight data, which was analyzed by a team of experts for
the past two months. That analysis revealed an important reduction in aerosol
emissions (50 percent) when using biofuel compared to conventional fuel.
Furthermore, additional tests performed on a static engine showed a significant
reduction in particles (up to 25 percent) and in black carbon emissions (up to
49 percent) compared to conventional fuel. The tests also revealed comparable
engine performance and an improvement of 1.5 percent in fuel consumption during
steady state operations. The jet's engines required no modification as the
biofuel tested in-flight meets the specifications of petroleum-based fuels. The
Falcon 20 aircraft operated on biofuel at 30,000 feet, similar to regular
commercial aircraft altitude. A second aircraft, the T-33, tailed the Falcon in
flight and measured engine emissions.


Agrisoma's Resonance(TM) based feedstock, used to produce the fuel, is a
dedicated industrial oilseed capable of growing on semi-arid land that was
launched at commercial scale in 2012 across western Canada.


More information about this biofuel initiative.

To view a video of Tim Leslie, NRC pilot, talking about the biofuel initiative,
click here.


About Calyx 

Calyx Bio-Ventures Inc. trades on the TSX Venture Exchange under the symbol
"CYX" and owns a majority position in Agrisoma Biosciences Inc. Agrisoma is an
agricultural biotechnology company that uses a proprietary Engineered Trait Loci
(ETL) technology licensed from Calyx to commercialize a suite of
industry-leading oil quality and crop improvement traits for use in energy
feedstock crops. For further information about Calyx, its technology,
collaborations and partnerships, please visit www.calyxbio.com.


Resonance(TM) is a trademark of Agrisoma Biosciences Inc. For more information
about Resonance, visit www.agrisoma.com.


ON BEHALF OF THE BOARD

CALYX BIO-VENTURES INC.

W. Hugh Notman, President & CEO

Forward-Looking Statements: This document contains certain forward-looking
statements concerning Calyx and/or Agrisoma, as well as other expectations,
plans, goals, objectives, information or statements about future events,
conditions, results of operations or performance that may constitute
"forward-looking statements" or "forward-looking information" under applicable
securities legislation. Such statements or information involve substantial known
and unknown risks and uncertainties, certain of which are beyond Calyx's and/or
Agrisoma's control, including general business, economic, competitive, political
and social uncertainties; the delay or failure to receive regulatory approvals,
the characteristics and viability for bio-fuel development, the willingness of
third parties to conclude agreements with Calyx and/or Agrisoma on terms that
are acceptable to management of Calyx and/or Agrisoma, and the ability of Calyx
and/or Agrisoma to secure sufficient future funding to carry out all of its
business plans.


Such forward-looking statements or information are based on a number of
assumptions which may prove to be incorrect. In addition to other assumptions
identified in this news release, assumptions have been made regarding, among
other things, commodity prices, operating conditions, capital and other
expenditures, and project development activities.


Although Calyx and/or Agrisoma believes that the expectations reflected in such
forward-looking statements or information are reasonable, undue reliance should
not be placed on forward-looking statements because Calyx and/or Agrisoma can
give no assurance that such expectations will prove to be correct.
Forward-looking statements or information are based on current expectations,
estimates and projections that involve a number of risks and uncertainties which
could cause actual results to differ materially from those anticipated by Calyx
and/or Agrisoma and described in the forward-looking statements or information.


The forward-looking statements or information contained in this news release are
made as of the date hereof and Calyx and/or Agrisoma undertakes no obligation to
update publicly or revise any forward-looking statements or information, whether
as a result of new information, future events or otherwise unless so required by
applicable securities laws or the TSX Venture Exchange. The forward-looking
statements or information contained in this news release are expressly qualified
by this cautionary statement.


This press release shall not constitute an offer to sell, nor the solicitation
of an offer to buy, any securities in the United States, nor shall there be any
sale of securities mentioned in this press release in any state in the United
States in which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such state.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Calyx Bio-Ventures Inc.
W. Hugh Notman
President & CEO
604-689-2495
hnotman@calyxbio.com


Calyx Bio-Ventures Inc.
Keir Reynolds
Investor Relations
778-998-9242
kreynolds@calyxbio.com
www.calyxbio.com

Grafico Azioni Calyx Ventures (TSXV:CYX)
Storico
Da Mag 2024 a Giu 2024

Grafico Azioni Calyx Ventures (TSXV:CYX)
Storico
Da Giu 2023 a Giu 2024